ID   BT142 mut/-
AC   CVCL_X501
DR   ATCC; ACS-1018
DR   cancercelllines; CVCL_X501
DR   SKIP; SKIP001284
DR   Wikidata; Q54798489
RX   PubMed=23757293;
CC   Group: Cancer stem cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:5382; IDH1; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (PubMed=23757293).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=23757293).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): ATCC=ACS-1018
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 12,14
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4050; Oligoastrocytoma
DI   ORDO; Orphanet_251656; Oligoastrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D718 ! BT142
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
RX   PubMed=23757293; DOI=10.1093/neuonc/not064; PMCID=PMC3714156;
RA   Luchman H.A., Chesnelong C., Cairncross J.G., Weiss S.;
RT   "Spontaneous loss of heterozygosity leading to homozygous R132H in a
RT   patient-derived IDH1 mutant cell line.";
RL   Neuro-oncol. 15:979-980(2013).
//